Mater Adult Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2009
NCT00960557
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Mater Hospital | Mater Misericordiae University Hospital, Dublin

Active Ingredients

Drugs in Phase 4 Trials (3)

lopinavir (Kaletra) (1 trial)

raltegravir (isentress) (1 trial)

ritonavir (Norvir) (1 trial)

Drugs in Phase 3 Trials (1)

colchicine (colbenemid) (1 trial)

Drugs in Phase 1 Trials (1)

oxi4503 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Ischemic Attack, Transient (Phase 3)

Liver Neoplasms (Phase 1)

Neoplasm Metastasis (Phase 1)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5